CE vs DVA · rev $10.28B vs P/E 14, rev $12.82B
Celanese Corporation (CE) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CE currently screens at market cap $5.92B. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CE and DVA stock pages for the full models.
Not investment advice.